Related Experiment Video

Updated: May 3, 2026

Experimental Metastasis Assay
08:28

Experimental Metastasis Assay

Published on: August 24, 2010

20.3K

GATA2 as a potential metastasis-driving gene in prostate cancer

Yan Ting Chiang1, Kendric Wang, Ladan Fazli

  • 1Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver BC, Canada.

Oncotarget
|January 23, 2014
PubMed

Insights

This study identified GATA2 as a key gene driving prostate cancer metastasis. Silencing GATA2 reduced cancer cell migration and invasion, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastatic prostate cancer requires effective treatments.
  • Identifying metastasis-driving genes is crucial for developing new therapies.

Purpose of the Study:

  • To identify metastasis-driving genes in prostate cancer.
  • To evaluate GATA2 as a potential therapeutic target for metastatic prostate cancer.

Main Methods:

  • Differential gene expression profiling of metastatic and non-metastatic prostate cancer xenografts.
  • Integrative analysis using Ingenuity Upstream Regulator Analysis.
  • GATA2 gene silencing in human prostate cancer cells (LNCaP).

Main Results:

  • Six candidate master regulatory genes were identified, including GATA2.
  • Elevated GATA2 expression correlated with poor patient prognosis in metastatic prostate cancer.
  • GATA2 gene silencing significantly reduced prostate cancer cell migration, invasion, and altered cell transcriptomes.

Conclusions:

  • GATA2 is a critical driver of prostate cancer metastasis.
  • GATA2 represents a potential therapeutic target for metastatic prostate cancer treatment.

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

14.0K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
6.4K